Literature DB >> 9446011

[Therapeutic plasma exchange 1996].

U Weber1, W Riegel, H Köhler.   

Abstract

Therapeutic plasma exchange (TPE) is an extracorporeal blood purification technique to remove large molecular weight substances. Since the late seventies TPE was used in a variety of diseases in which humoral factors may play a part in the pathogenesis. Today, accepted indications only exist for a few entities in defined situations: Anti-glomerular basement membrane antibody mediated disease, TTP/HUS, Guillain-Barré-syndrome, hyperviscosity syndrome, chronic polyneuropathy associated with IgG and IgA gammopathy, chronic inflammatory demyelinating polyneuropathy and myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9446011     DOI: 10.1007/bf03044789

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  97 in total

1.  Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement.

Authors:  P A van Doorn; M Vermeulen; A Brand; P G Mulder; H F Busch
Journal:  Arch Neurol       Date:  1991-02

2.  High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.

Authors:  P A van Doorn; A Brand; P F Strengers; J Meulstee; M Vermeulen
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

Review 3.  Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyneuropathy.

Authors:  K Heininger; E Gibbels; U A Besinger; H Borberg; H P Hartung; B Grabensee; K V Toyka
Journal:  Prog Clin Biol Res       Date:  1990

4.  Treatment of severe iodine-induced hyperthyroidism with plasmapheresis.

Authors:  O Segers; H Spapen; L Steenssens; R Cytryn; M H Jonckheer; L Vanhaelst
Journal:  Acta Clin Belg       Date:  1988       Impact factor: 1.264

5.  Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.

Authors:  J O Schroeder; H H Euler; H Löffler
Journal:  Ann Intern Med       Date:  1987-09       Impact factor: 25.391

Review 6.  [Goodpasture syndrome. Progress in immunopathogenesis, diagnosis and therapy].

Authors:  M Weber; M Marx; F Merkel
Journal:  Internist (Berl)       Date:  1995-03       Impact factor: 0.743

Review 7.  Current status of therapeutic plasmapheresis and related techniques. Report of the AMA panel on therapeutic plasmapheresis. Council on Scientific Affairs.

Authors: 
Journal:  JAMA       Date:  1985-02-08       Impact factor: 56.272

8.  Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia.

Authors:  W H Sherman; M R Olarte; G McKiernan; K Sweeney; N Latov; A P Hays
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

9.  Plasma exchange in chronic inflammatory polyneuropathy: evidence suggestive of a pathogenic humoral factor.

Authors:  K V Toyka; R Augspach; H Wiethölter; U A Besinger; F Haneveld; U G Liebert; K Heininger; G Schwendemann; K Reiners; B Grabensee
Journal:  Muscle Nerve       Date:  1982 Jul-Aug       Impact factor: 3.217

10.  Experience with intravenous immunoglobulin in myasthenia gravis.

Authors:  E Arsura
Journal:  Clin Immunol Immunopathol       Date:  1989-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.